A water-soluble, stable dipeptide NK1 receptor-selective neurokinin receptor antagonist with potent in vivo pharmacological effects: S18523

European Journal of Pharmacology

Volumn 310, Issue 1, 1996, Pages 37-46

  Bonnet, Jacqueline ^a   Kucharczyk, Nathalie ^a   Robineau, Pascale ^a   Lonchampt, Michel ^a   Dacquet, Catherine ^a   Regoli, Domenico ^b   Fauchère, Jean Luc ^a   Canet, Emmanuel ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Bronchoconstriction; Neurokinin; Neuropeptide; NK1 receptor antagonist; Pain; Plasma extravasation

Indexed keywords

3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; DIPEPTIDE; ISRADIPINE; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 2 RECEPTOR; S 18523; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOASSAY; BRONCHOSPASM; CONTROLLED STUDY; DRUG RECEPTOR BINDING; EXTRAVASATION; GUINEA PIG; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT; RAT;

EID: 0030598125     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00362-7     Document Type: Article

References (52)

1. Advenier, C., E. Naline, G. Drapeau and D. Regoli, 1987, Relative potencies of neurokinins, in guinea-pig trachea and human bronchus, Eur. J. Pharmacol. 139, 133.
2. Arunlakshana, O. and H.O. Schild, 1959, Some quantitative uses of drug antagonists, Br. J. Pharmacol. 14, 48.
3. Barnes, P.J., J.N. Baraniuk and M.G. Belvisi, 1991, Neuropeptides in the respiratory tract, Am. Rev. Respir. Dis. 144, 1187.
4. 1 tachykinin receptors, Am. Rev. Resp. Dis. 148, 909.
5. Carter, M.S. and J.E. Krause, 1990, Structure, expression and some regulatory mechanisms of the rat preprotachykinin gene encoding substance P, neurokinin A, neuropeptide K and neuropeptide γ, J. Neurosci. 10, 2203.
6. i and the concentration of inhibitor which causes 50 per cent inhibition of an enzymatic reaction, Biochem. Pharmacol. 22, 3099.
7. 1 receptors in vitro, Br. J. Pharmacol. 114, 351P.
8. Dubuisson, D. and S.G. Dennis, 1977, The formalin test as a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats, Pain 4, 164.
9. Duggan, A.W., I.A. Hendry, C.R. Morton, W.D. Hutchison and Z.Q. Zhoa, 1988, Cutaneous stimuli releasing immunoreactive substance P in the dorsal horn of the cat, Brain Res. 451, 261.
10. Eddy, N.B. and D. Leimbach, 1953, Synthetic analgesics diethienylbutyenyl and dithienylbutylamines, J. Pharmacol. Exp. Ther. 107, 385.
11. 1 receptor antagonist, Eur. J. Pharmacol. 250, 403.
12. Fauchère, J.L. and R. Schwyzer, 1981, Differential protection and selective deprotection in peptide synthesis, in: The Peptides, Analysis, Synthesis, Biology, Vol. 3, eds. E. Gross and J. Meienhofer (Academic Press, London) pp. 203.
13. Folkers, K., D.M. Feng, N. Asano, R. Häkanson, Z. Weisenfeld-Hallin and S. Leander, 1990, Spantide II, an effective tachykinin antagonist having high potency and negligible toxicity, Proc. Natl. Acad. Sci. USA 87,4833.
14. 1 receptor antagonist, FK888, Br. J. Pharmacol. 107, 785.
15. Garret, C., A. Carruette, V. Fardin, S. Moussaqui, J.F. Peyronel, J.C. Blanchard and P.M. Laduron, 1991, Pharmacological properties of a potent and selective nonpeptide substance P antagonist, Proc. Natl. Acad. Sci. USA 88, 10208.
16. Glossmann, H., R. Hornung and P. Presek, 1980, The use of ligand binding for the characterisation of α-adrenoreceptors, J. Cardiovasc. Pharmacol. 2, S303.
17. Goldstein, A. and A. Naidu, 1989, Multiple opioid receptors: ligand selectivity profiles and binding site signatures, Mol. Pharmacol. 36, 265.
18. Guard, S. and K. Watling, 1992, Interaction of the non peptide NK-1 tachykinin receptor antagonist (±) CP 96345 with L-type calcium channels in rat cerebral cortex, Br. J. Pharmacol. 106, 37P.
19. 3H]-Hydroxy-2-(di-n-propylamino)tetralin binding to pre-and postsynaptic 5-hydroxy-tryptamine sites in various regions of the rat brain, J. Neurochem. 44, 1685.
20. Henry, J.L., 1987, Discussions of nomenclature for tachykinins and tachykinin receptors, in: Substance P and Neurokinins, eds. J.L. Henry et al. (Springer, New York) pp. XVII-XVIII.
21. 3H]-SCH23390-labeled D1 dopamine receptors in rat striatum, Eur. J. Pharmacol. 121, 31.
22. Hill, S.J. and Young, J.M. 1980, Histamine H1-receptors in the brain of the guinea-pig and the rat: differences in ligand binding properties and regional distribution, Br. J. Pharmacol. 68, 687.
23. Holzer, P., 1988, Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene related peptide and other neuropeptides. Neuroscience 24, 739.
24. 3H]-RX821002: a highly selective ligand for the identification of alpha2-adrenoreceptors in the rat brain, Mol. Neuropharmacol. 1, 219.
25. Johnson, A.R. and N.C. Moran, 1966, Comparison of several methods for isolation of rat peritoneal mast cells, Proc. Soc. Exp. Biol. Med. 123, 886.
26. 3H]-raclopride, Biochem. Pharmacol. 34, 2251.
27. Kucharczyk, N., C. Thurieau, J. Paladino, A. Morris, J. Bonnet, E. Canet, J.E. Krause, D. Regoli, R. Couture and J.L. Fauchère, 1993, Tetrapeptide tachykinin antagonists: synthesis and modulation of the physicochemical and pharmacological properties of a new series of partially cyclic analogs, J. Med. Chem. 36, 1654.
28. 3H]-ligand for serotonin-2-receptors binding sites, Mol. Pharmacol. 21, 301.
29. Longmore, J., C.J. Swain and R.G. Hill, 1995, Neurokinin receptors, Drug News Perspect. 8, 5.
30. Lowman, M.A., R.C. Benyon and M.K. Church, 1988, Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells, Br. J. Pharmacol. 95, 121.
31. Lundberg, J.M., A. Saria, E. Broodin, S. Rosell and K. Folkers, 1983, A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea-pig, Proc. Natl. Acad. Sci. USA 80, 1120.
32. MacLeod, A.M., K.J. Merchant, M.A. Cascieri, S. Sadowski, E. Ber, C.J. Swain and R. Baker, 1993, N-Acyl-L-tryptophan-benzyl esters: potent substance P receptor antagonists, J. Med. Chem. 36, 2044.
33. McLean, S., A. Ganong, P.A. Seymour, R.M. Snider, J.C. Desai, T. Rosen, D.K. Bryce, K.P. Longo, L.S. Reynolds, G. Robinson, A.W. Schmidt, C. Siok and J. Heym, 1993, Pharmacology of CP 99994, a nonpeptide antagonist of the tachykinin neurokinin-1 receptor, J. Pharmacol. Exp. Ther. 267, 472.
34. Morimoto, H., M. Murai, Y. Maeda, D. Hagiwara, H. Miyake, M. Masaaki and T. Fujii, 1992, FR 113680: a novel stripeptide substance P antagonist with NK1 receptor selectivity, Br. J. Pharmacol. 106, 123.
35. 3 binding in rat brain cortical membranes, Biochem. Pharmacol. 38, 1693.
36. Otsuka, M. and K. Yoshioka, 1993, Neurotransmitter functions of mammalian tachykinins, Physiol. Rev. 73, 273.
37. Paladino, J., N. Kucharczyk, A.D. Morris, M. Thibault-Naze, J.P. Mahieu, B. Serkiz, J.P. Volland, C. Autissier and J.L. Fauchère, 1994, Estimation of blood levels of endothelin and neurokinin receptor antagonists at the rat portal and jugular veins after oral administration as a tool in peptide drug design, Drug Design Discov. 12, 121.
38. Payan, D.G., J.P. McGillis and M.L. Organist, 1986, Binding characteristics and affinity labelling of protein constituents of the human IM-9 lymphoblast receptor for substance P, J. Biol. Chem. 261, 14321.
39. Regoli, D., G. Drapeau, S. Dion and R. Couture, 1988, New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization, Trends Pharmacol. Sci. 9, 290.
40. Regoli, D., A. Boudon and J.L. Fauchère, 1994a, Receptors and antagonists for substance P and related peptides, Pharmacol. Rev. 46, 551.
41. Regoli, D., Q.T. Nguyen and D. Jukic, 1994b, Neurokinin receptor subtypes characterised by biological assays, Life Sci. 54, 2035.
42. Rogers, D.F., M.G. Belvisi, B. Aursudkij, T.W. Evans and P.J. Barnes, 1988, Effects and interactions of sensory neuropeptides on airway microvascular leakage in guinea-pigs, Br. J. Pharmacol. 95, 1109.
43. Roskoski, R., R. Guthrie, L.M. Roskoski and W. Rossowski, 1985, Degradation of rat brain cholinergic muscarinic receptors in vitro: enhancement by agonist and inhibition by antagonists, J. Neurochem. 45, 1096.
44. Saria, A., J.M. Lundberg, G. Skoftisch and F. Lembeck, 1983, Vascular protein leakage in various tissues induced by substance P, capsaicin, bradykinin, serotonin, histamine and by antigen challenge, Naunyn-Schmiedeberg's Arch. Pharmacol. 324, 212.
45. 2+ channels, Eur. J. Pharmacol. 215, 351.
46. Siegmund, E., R. Cadmus and Go Lu, 1957, A method for evaluating both non-narcotic and narcotic analgesics, Proc. Soc. Exp. Biol. Med. 95, 729.
47. Snider, R.M., J.W. Constantine, J.A. Lowe III, K.P. Longo, W.S. Lebel, H.A. Woody, S.E. Drozda, M.C. Desai, F.J. Vinick, R.W. Spencer and H.J. Hess, 1991, A potent non-peptide antagonist of the substance P (NK1) receptor, Science 251, 435.
48. Tabart, M. and J.F. Peyronel, 1994, Synthesis of RPR 100 893, prototype of a new series of potent and selective non peptide NK1 antagonists: the triarylperhydroisoindolols, Bioorg. Med. Chem. Lett. 4, 673.
49. Takeda, Y., P. Blount, A.D. Hershey, R. Raddatz, B.S. Sachais and J.E. Krause, 1992, Ligand binding kinetics of substance P and neurokinin A receptors stably expressed in CHO cells and evidence for differential stimulation of inositol 1,4,5-triphosphate and cyclic AMP second messenger response, J. Neurochem. 59, 740.
50. Tattershall, F.D., W. Rycroft, R.J. Hargreaves and R.G. Hill, 1994, Enantioselective inhibition of apomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99 994, Neuropharmacology 33, 259.
51. Watling, K.J. and J.E. Krause, 1993, The rising sun shines on substance P and related peptides, Trends Pharmacol. Sci. 14, 81.
52. Zimmermann, M., 1983, Ethical guidelines for investigation of experimental pain in conscious animals, Pain 16, 109.